CSL Ltd

CSL: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|yrLOCK|t$TDLOCK|@nH!<>

CSL: Facing Headwinds but Shares Undervalued as We Expect Resilient Plasma Demand and Margins

We transfer coverage of CSL, a global leader in plasma therapies, influenza vaccinations, and iron and kidney products. Shares have plummeted over 60% in the last two years on several earnings downgrades, significant impairments, and fiercer competition.

Sponsor Center